# ClinicalTrials.gov record NCT02911818

> PeptideScanner retained ClinicalTrials.gov record NCT02911818 at 2026-07-30T20:52:10.188Z. Its registry update date was 2019-05-07, and PeptideScanner's reviewed identity mapping was liraglutide.

- Evidence object: `story:clinicaltrials-gov-nct02911818-liraglutide:v1`
- Evidence domain: Clinical trials
- Date in source: 2019-05-07
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct02911818-liraglutide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct02911818-liraglutide-v1.json
- Content SHA-256: `30282a874a2b6502dbaeb964c3f82bc74e8f96fe19881ac2fa5ecbbba50cb08b`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT02911818 ([`ctg-observation-nct02911818-2019-05-07-df7cafc81a9c`](#source-ctg-observation-nct02911818-2019-05-07-df7cafc81a9c))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT02911818 at 2026-07-30T20:52:10.188Z. Its registry update date was 2019-05-07, and PeptideScanner's reviewed identity mapping was liraglutide. ([`ctg-observation-nct02911818-2019-05-07-df7cafc81a9c`](#source-ctg-observation-nct02911818-2019-05-07-df7cafc81a9c))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT02911818 at 2026-07-30T20:52:10.188Z. Its registry update date was 2019-05-07, and PeptideScanner's reviewed identity mapping was liraglutide. ([`ctg-observation-nct02911818-2019-05-07-df7cafc81a9c`](#source-ctg-observation-nct02911818-2019-05-07-df7cafc81a9c))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct02911818-2019-05-07-df7cafc81a9c`](#source-ctg-observation-nct02911818-2019-05-07-df7cafc81a9c))

## Sources

<a id="source-ctg-observation-nct02911818-2019-05-07-df7cafc81a9c"></a>
- **ClinicalTrials.gov record NCT02911818 · retained source version 2019-05-07:df7cafc81a9c9f2726b3dbf4d8160fa69da9d905cf3df68b3b273c75a928088e** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT02911818) (`ctg-observation-nct02911818-2019-05-07-df7cafc81a9c`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT02911818." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct02911818-liraglutide-v1.json SHA-256: 30282a874a2b6502dbaeb964c3f82bc74e8f96fe19881ac2fa5ecbbba50cb08b.